Search results
Publications. PubMed. Home / Staff Members / Alessandro Bonifazi, Ph.D. The National Institute on Drug Abuse Intramural Research Program is a research facility in Baltimore, MD. The NIDA IRP dedicated to understanding the causes, consequences and treatment of drug abuse.
Alessandro Bonifazi. Highly Selective Dopamine D 3 Receptor (D 3 R) Antagonists and Partial Agonists Based on Eticlopride and the D 3 R Crystal Structure: New Leads for Opioid …. V Kumar, A Bonifazi, MP Ellenberger, TM Keck, E Pommier, R Rais, ... M Sánchez-Soto, A Bonifazi, NS Cai, MP Ellenberger, AH Newman, ...
Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D. 3. (D. 3. R) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics. Article authors Lily Saab, BS and Alessandro Bonifazi, Pharm.D./Ph.D. Featured Paper of the Month – December 2023.
Alessandro BONIFAZI, Research Fellow | Cited by 1,273 | of National Institute on Drug Abuse, Maryland (NIDA) | Read 69 publications | Contact Alessandro BONIFAZI.
Novel atypical inhibitors of the dopamine transporter and partial agonists/antagonists at dopamine D 3 receptors (D 3 R) are described as two promising targets for future drug development. Newman, Amy Hauck; Ku, Therese; Jordan, Chloe J; Bonifazi, Alessandro; Xi, Zheng-Xiong.
My main research interest is in urban sustainability, with a focus on ecological planning and civic engagement. My current lines of research include local energy transitions and climate change adaptation, urban and environmental commons, urban food strategies, urban sprawl and soil sealing, and integrated coastal planning.
Aug 10, 2023 · Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D. 3. (D. 3. R) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics. J Med Chem. 2023 Aug 10;66 (15):10304-10341. doi: 10.1021/acs.jmedchem.3c00417. Epub 2023 Jul 19.
